Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants

NCT06545253 is registered in ClinicalTrials.gov with IRCCS Ospedale San Raffaele as lead sponsor.

NCT NCT06545253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06545253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A New Diagnostic Paradigm for Retinitis Pigmentosa Secondary to USH2A Pathogenic Variants
Lead sponsor
IRCCS Ospedale San Raffaele
Phase
Observational
Overall status
Not yet recruiting
Start date
August 31, 2024
Completion date
February 28, 2027
Enrollment
60 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ush2a variant retinitis pigmentosa